NeonMind Biosciences Inc. Stocks

CA$ 0Last Updated 23.03.2026

Issuer Rating

Performance

Poor

Risk

High

Recommendation

Sell

Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CA$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

NeonMind Biosciences Inc. operates as an integrated psychedelic drug development and wellness company in Canada. The company provides psychedelic drugs to address public health needs, including obesity, weight management, and mental health. It operates in two divisions, Pharmaceutical and Medical Services. The company offers drug development research services for the potential therapeutic uses of psychedelic compounds, as well as focuses on launching specialty mental health clinics that integrate psychedelic therapeutics into traditional psychotherapy settings. The company was formerly known as Flourish Mushroom Labs Inc. and changed its name to NeonMind Biosciences Inc. in April 2020. NeonMind Biosciences Inc. was incorporated in 2019 and is based in Oakville, Canada.

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks